Arthur Krieg to Drug Design
This is a "connection" page, showing publications Arthur Krieg has written about Drug Design.
Connection Strength
0.328
-
Krieg AM. Development of TLR9 agonists for cancer therapy. J Clin Invest. 2007 May; 117(5):1184-94.
Score: 0.261
-
Krieg AM, Vollmer J. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev. 2007 Dec; 220:251-69.
Score: 0.068